1 – 10 of 102
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Reflections on the Lancet Commission on Investing in Health's Global Health 2050 report – Authors' reply
(
- Contribution to journal › Letter
-
Mark
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH) : a randomised, open-label, phase 2/3 superiority trial
2025) In The Lancet(
- Contribution to journal › Article
-
Mark
Integrating environmental outcomes in randomised clinical trials : a call to action
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2) : a multicentre, participant-masked, registry-based, randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1) : a multicentre, participant-masked, registry-based, randomised controlled trial
(
- Contribution to journal › Article
- 2024
-
Mark
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE) : a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
(
- Contribution to journal › Article
-
Mark
First dose of misoprostol administration at home or in hospital for medical abortion between 12–22 gestational weeks in Sweden (PRIMA) : a multicentre, open-label, randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART) : a single-blind, non-inferiority, registry-based, randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Haemodiafiltration versus haemodialysis for kidney failure : an individual patient data meta-analysis of randomised controlled trials
(
- Contribution to journal › Article
-
Mark
Global health 2050 : the path to halving premature death by mid-century
(
- Contribution to journal › Scientific review